Previous 10 | Next 10 |
Guardforce AI (GFAI) +46% is expanding it footprint by establishing subsidiaries in Dubai and Australia. IGM Biosciences (IGMS) +32% on proposed stock offering. Hycroft Mining Holding (HYMC) +23% GameStop, AMC and Bed Bath pull off a meme stock comeback. Nielsen Holdi...
Palm Beach, FL – March 24, 2022 – FinancialNewsMedia.com News Commentary – The status of breast cancer as one of the most commonly occurring cancers in the world is expected to be a key driving factor for the global market. As more and more patients are diag...
Gainers: Creative Medical Technology CELZ +99%. 4D pharma LBPS +87%. Femasys FEMY +21%. Revelation Biosciences (REVB) +19%. NeuroSense Therapeutics (NRSN) +7%. Losers: Cue Health (HLTH) -17%. Codex DNA (DNAY) -17%. PetVivo (PETV) -14%. Yumanity The...
Buying Penny Stocks Today? Here’s What You Need to Know With another day of trading penny stocks and blue chips here, there is a lot for investors to consider. After a few interesting and mostly bullish days of trading, those who invest in penny stocks are excited for the nea...
4D pharma (NASDAQ:LBPS) said its drug MRx0518 in combination with Merck's (MRK) Keytruda met the main efficacy goal early in patients with kidney cancer group in Part B of a phase 1/2 study. The ongoing study is being conducted in heavily pre-treated metastatic patients with solid tumors...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Rise and shine, trader! We’re starting off the day with a breakdown of the biggest pre-market stock movers for Wednesday! Source: oneinchpunch/Shutterstock.com Earnings reports, an uplisting, clinical trial r...
- Primary Efficacy Endpoint Met Early in Renal Cell Carcinoma Group in Part B of Study - Company to Host Conference Call and Webcast Today March 23, 10:00 am EST (2:00 pm GMT) 4D pharma plc (AIM: DDDD, NASDAQ: LBPS) , a pharmaceutical company leading the development of L...
Gainers: Zhongchao (NASDAQ:ZCMD) +35%. Moderna (NASDAQ:MRNA) +15%. ERYTECH Pharma (NASDAQ:ERYP) +14%. Allied Healthcare Products (NASDAQ:AHPI) +13%. 4D pharma (NASDAQ:LBPS) +13%. Losers: Nektar Therapeutics (NASDAQ:NKTR) -53%. MultiPlan (NYSE:MPLN) -26%. ...
Volt Information Sciences (NYSE:VOLT) +96% on acquisition proposal from ACS Solutions affiliate. Zhongchao (NASDAQ:ZCMD) +41%. Turquoise Hill Resources (NYSE:TRQ) +31% after receiving Rio Tinto's takeover proposal. Amphastar Pharmaceuticals (NASDAQ:AMPH) +24%. Mullen Autom...
Gainers: Clearside Biomedical CLSD +38%. Cellectis (NASDAQ:CLLS) +13%. NeuroPace (NASDAQ:NPCE) +12%. 4D pharma LBPS +11%. LifeStance Health (NASDAQ:LFST) +8%. Losers: Orphazyme ORPH -37%. Aesthetic Medical International (NASDAQ:AIH) -19%. Suns...
News, Short Squeeze, Breakout and More Instantly...
4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announces that on June 27, 2022, it received written notice from The Nasdaq Stock Market LLC (ȁ...
4D pharma plc (AIM: DDDD, Nasdaq: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, provides an update to the announcement released earlier today regarding the Company’s request for a...
- Study to assess safety of MRx0518 with BAVENCIO and effect on progression-free survival at 6 months - Study sites are open for patient enrolment 4D pharma plc (AIM: DDDD, NASDAQ: LBPS) , a pharmaceutical company leading the development of Live Biotherapeutic products (LB...